Rani Mukerji is all set to reprise her role as tough cop in Mardaani 3. The film, which announcement was made in 20204, shoot will be starting from June this year. The makers are currently working on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Mardaani 3, the next installment in the Rani Mukerji-led cop franchise, was officially announced in 2024. Fans have been eagerly waiting for updates about the movie. It has now been learned that ...

Bollywood actress Rani Mukerji is all set to reprise the role of a tough police officer in the third part of her hit film Mardaani. According to reports in Mid-Day, the actress will be starting ...

When Aishwarya Rai appeared on the show Jeena Isi Ka Naam Hai, Rani Mukerji sent a heartfelt video message to her. Manisha Chauhan Updated : Feb 18, 2025, 11:11 AM IST | Edited by : Manisha Chauhan ...

One such well-known bond was between Aishwarya Rai and Rani Mukerji. Once inseparable, their friendship took an unfortunate turn after a major incident involving Salman Khan, leading to a permanent ...

Rani Mukerji had told Aishwarya Rai once that they will always be friends. However, Rani had replaced Aishwarya in 'Chalte Chalte' after the latter was removed from the film by the producers.

To get a sense of who is truly in control of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), it is important to understand the ownership structure of the business. And the group that holds the ...

They trailed 0-1 at halftime in the gold medal match and were struggling. However, their captain and Indian hockey legend Rani Rampal inspired the team to a fine comeback, as Haryana banged four goals ...

Athangudi tiles have become a signature in Chettinad households and homestays. Today, Athangudi tiles are celebrated not only for their aesthetic appeal but also for their cultural significance. These ...

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.